The FDA posts Medical Device Safety Communications to describe the FDA's current analysis of an issue and contain specific regulatory approaches and clinical recommendations for patient management.

2022 Safety Communications

Device Name	Date
Do Not Use Certain ACON Flowflex COVID-19 Tests: FDA Safety Communication	03/01/2022
Do Not Use SD Biosensor STANDARD Q COVID-19 Ag Home Tests: FDA Safety Communication	03/01/2022
Do Not Use Certain Celltrion DiaTrust COVID-19 Tests: FDA Safety Communication	03/01/2022
Potential Risk of Strangulation in Children Who Use Enteral Feeding Delivery Sets - FDA Safety Communication	02/08/2022
Do Not Use E25Bio COVID-19 Tests: FDA Safety Communication	02/04/2022
Stop Using Empowered Diagnostics COVID-19 Tests: FDA Safety Communication	01/28/2022
Update on Risk of Type III Endoleaks with Use of Endologix AFX Endovascular AAA Graft Systems - FDA Safety Communication	01/13/2022
Stop Using LuSys Laboratories COVID-19 Tests: FDA Safety Communication	01/11/2022